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ABSTRACT
DNA PLASMID PURIFICATION PROCESS OPTIMIZATION
AT LIFE TECHNOLOGIES CORPORATION
Trevor Shepherd

This project focused on optimizing the plasmid DNA purification process at Life
Technologies. These plasmids are designed to code for specialized proteins used by
research universities, national laboratories, or research companies. Once cultivated
and harvested, the plasmids must be analyzed for quality and quantity. The project is
divided into improving three aspects of the process: 1) plasmid identification, 2) plasmid
purity evaluation, and 3) process yield. Plasmid identification is now simpler, more
robust and has zero ambiguity. Plasmid purity evaluation is now measured with
computer software, which reduces user error and eliminates subjectivity. Using the
nascent metrics provided by the improved identification and purity evaluation
techniques, process yield was analyzed and improved. The hypotheses on yield
improvement and the information gleaned from their resulting experiments provide a
foundation for further process improvement.

iv

ACKNOWLEDGEMENTS
I would like to thank Mark Cochran for his deep knowledge of the science and steady
patience throughout my time at Life Technologies and while I was writing my thesis.
Also, I would like to thank Trevor Cardinal and Lanny Griffin for being part of my thesis
committee and providing guidance throughout this project. Finally, I would like to thank
Life Technologies for providing the opportunity to work with them.

v

TABLE OF CONTENTS
Page
LIST OF TABLES…………………………………………………………………viii
LIST OF FIGURES………………………………………………………………..ix
CHAPTER
I.

Introduction…………………………………………………………….1
Life Technologies Synopsis……………………………………...1
Project Overview…………………………………………………..2
Technical Background……………………………………………3
Shortcomings of the DNA Purification Process………………..19

II.

Objectives and Approach……………………………………………..20
Improving the Identification Protocol…………………………….20
Improving the Purity Analysis Protocol………………………….21
Improving the Yield of the Purification Process………………..22

III.

Methods and Materials………………………………………………..23
Improving the Identification Protocol…………………………….23
Improving the Purity Analysis Protocol………………………….31
Improving the Yield of the Purification Process……………….. 39

IV.

Results and Discussion……………………………………………….42
vi

Identification Assay………………………………………………..42
Purity Assay………………...………………………………………45
Yield Assay…………………………………………………………51
V.

Conclusion and Future Works………………………………………..58
Identification Assay……………………………………………58
Purity Assay…………………………………………………….58
Yield Assay……………………………………………………..59

Bibliography..……………………………………………………………………….60

vii

LIST OF TABLES
Table

Page

1. Raw Density Data From VisionWorksLS Software……………………38
2. MegaPrep/GigaPrep Specifications…………………………………….40
3. Purity Calculations………………………………………………………..46
4. Plasmid Characterization………………………………………………...48
5. GigaPrep Purity and Yield Assay Results……………………………...52
6. Maxicard Purity and Yield Assay Results………………………………55

viii

LIST OF FIGURES
Figure

Page

1. Storage Freezer…………………………………………………………...4
2. Individual “Glycerol Stock” On Ice……………………………………….4
3. Plasmid Map……………………………………………………………….5
4. Diagram of Transformation………………………………………………6
5. Plasmid Transformation Station…………………………………………7
6. Illustration of Antibiotic Resistance Selection………………………….8
7. Petri Dish with Transformed Bacteria Colonies………………………..9
8. New Brunswick C-24 Incubator and Shaker……………………………10
9. Large Scale Innoculation…………………………………………………11
10. Sorvall RC3B Centrifuge………………………………………………….12
11. Bacteria Pellet……………………………………………………………...12
12. Filtration and Purification Station………………………………………...13
13. DNA Pellet…………………………………………………………………..14
14. Nanodrop Spectrophotometer…………………………………………….15
15. Restriction Enzyme Reactions……………………………………………16
16. Electrophoresis Gel Box…………………………………………………...17
17. DNA Electrophoresis Gel…………………………………………………..18
18. Previous Electrophoresis Gel……………………………………………...22
ix

19. Raw Plasmid Sequence……………………………………………………24
20. Vector NTI Pictorial of Plasmid…………………………………………….25
21. Life Technologies Product Manual Sequence Description……………..26
22. Molecular Structure Illustration……………………………………………27
23. Typical Sequencing Read-out…………………………………………….28
24. ID Sequence Lay-out………………………………………………………29
25. ContigExpress………………………………………………………………30
26. E-Gel with “Smiley Faces”…………………………………………………31
27. Hand-Poured Gel…………………………………………………………...32
28. 2UV Transilluminator……………………………………………………….33
29. Density Box…………………………………………………………………..33
30. VisionWorksLS Imaging Software Interface……………………………...34
31. Electrophoresis Banding Pattern…………………………………………..35
32. Electron Micrograph Image of Bacterial DNA…………………………….36
33. Defined Density Boxes………………………………………………………37
34. Filtration Cartridge……………………………………………………………39
35. Maxicard Purification Machine……………………………………………...41
36. Sequence Data……………………………………………………………….42
37. SeqID File……………………………………………………………………..43
38. ContigExpress Identification Evaluation…………………………………...44
39. Purity Evaluation Verification Gel…………………………………………...45
40. Pixel Density vs Volume……………………………………………………...47
41. Genomic Contamination vs Plasmid Size (bp)……………………………..49

x

42. Genomic Contamination vs Purification Scale……………………………..50
43. MegaPrep Purity vs Bacteria Quantity………………………………………53
44. MegaPrep Purity vs Efficiency……………………………………………….54
45. Maxicard Purity vs Efficiency…………………………………………………56
46. Maxicard Purity vs Plasmid Size……………………………………………...56

xi

I.

Introduction

Life Technologies Synopsis
Life Technologies is a life science tools company which employs approximately
11,000 people, holds approximately 4,000 patents, and markets over 50,000
products. The company’s list of products can be divided into two basic
categories: consumables and diagnostics.
The consumable products are specifically designed DNA, RNA and proteins.
These are typically used by research universities, national laboratories, or
research companies as the basic materials for investigating diseases,
pharmacology, tissue engineering and genetic engineering. The diagnostic
products are the tools used to manipulate and evaluate utilization of the
consumable products. Some of Life Technologies’ most notable diagnostic
products are: Ion Torrent®, which utilizes a state-of-the-art technology to rapidly
sequence genetic code; Dynabeads®, which uses magnetic and surface
properties to separate cells; and Purelink® Separation Products, which automate
the multi-step processes of isolating DNA or RNA.
The size and scope of Life Technologies evolved through numerous mergers and
acquisitions over the last 30+ years, resulting in a strategic amalgamation of both
complimentary and competing companies. While the succession of coalescing
companies has been successful, each nascent product acquisition requires a reworked production process to efficiently incorporate it into the aggregate.
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Project Overview
This project focuses on optimizing Life Technologies’ in-house DNA Plasmid
Manufacturing Process. A plasmid is a small circle of DNA which can replicate
independently of the host cell chromosome. Typically, this DNA has been
ordered by a customer for the production of a desired recombinant protein.
These recombinant proteins have been molecularly cloned from their natural
source, typically bacteria, and engineered for specific expression systems.
When researching proteins, it is extremely useful to modify them so they are
easily identified and separated. These strategies are effected by designing DNA
into the plasmids which code for resistance to an antibiotic, and/or for a particular
tag.
A simple yet effective way of separating a desired host-cell type from an
undesired host-cell type is to destroy the undesired cells with an antibiotic.
Implementation of this strategy involves proliferation in a medium containing an
antibiotic. Any cell not containing the DNA that codes for protection against the
antibiotic will be destroyed.
DNA designed to code for particular tags allow separation/identification at the
protein level. Protein tags are genetically grafted onto the recombinant protein of
interest. Two of the most common types of tags are epitope and fluorescence;
these tags create high antibody affinity and enable fluorescent illumination,
respectively.
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Once a plasmid is designed, it must be proliferated in a cell culture and purified.
The basic outline of the DNA purification process follows these steps: 1) obtain
the desired plasmid; 2) transform the plasmid into a specialized strain of E. coli
bacteria; 3) proliferate the transformed bacteria; 4) harvest the desired DNA; and
5) analyze and verify the DNA identity, purity and concentration. Steps 4 and 5
needed the most improvement and are where the majority of the project was
focused.

Technical Background
Step 1: Obtain Plasmid
Life Technologies categorically stores hundreds of plasmids, recombinant DNA
designed to produce specific complimentary combinations of proteins. These
stored plasmids are referred to as “Glycerol Stock”, and are stored in a mixture of
glycerol and TE Buffer (TE) at -80°C. The mixture safely stores the plasmids by
maintaining the appropriate pH of approximately 8.0, chelating the metal ions that
activate degrading nucleases, and it does not crystallize at this temperature
which greatly reduces shear stress on the DNA.
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Figure 1. Storage Freezer. Plasmids contained in mini-tubes and stored in
categorically organized boxes in a -80°C freezer.

Figure 2. Individual “Glycerol Stock” On Ice. These Mini-tubes contain the
stored plasmid suspended in glycerol and TE buffer. The DNA is kept cold to
reduce molecular interaction which prevents degradation.
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Figure 3. Plasmid Map. Example of Life Technologies’ visual depiction of a
plasmid.

The map shows the regions where specified proteins are coded, the number of
base pairs, and the restriction enzyme recognition sites.

Step 2: Plasmid Transformation
Once the plasmid has been selected, it must be transformed into a cell for
proliferation and then harvested from the bacteria culture. The bacteria cell wall
5

is the biggest barrier to DNA uptake. To pass the cell wall, a modified noninfectious strain of E. coli bacteria is mixed with the plasmid in saline solution.
The mixture is then heated to 42°C, causing the wall of the cell to become porous
enough for the plasmid to enter. Once transformed, the plasmid can be
multiplied within the cell independently of the bacteria genome because it
contains its own origin of replication.

Figure 4. Diagram of Transformation. This illustration depicts the incorporation
of a recombinant bacteria plasmid into a host cell.
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Figure 5. Plasmid Transformation Station. This is the warm water bath (42°C)
where transformation occurs. Hosts are briefly “shocked” by the warm water
allowing the plasmid to enter the cell. Once incorporated, the cell has the
molecular framework to facilitate proliferation of the plasmid in addition to its own
genomic DNA.

Step 3: Proliferating the Transformed Bacteria
The bacteria transformed with the plasmid of interest are then smeared onto an
agar plate in a petri dish and incubated for 12 hours. The agar provides a
suitable growth environment and contains the appropriate antibiotic. After
incubation, individual colonies appear on the agar where a successfully
transfected bacteria has proliferated. The antibiotic destroys all cells which have
not incorporated the plasmid of interest and its constituent antibiotic resistance
gene.
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Figure 6. Illustration of Antibiotic Resistance Selection. This is a very effective
way of easily distinguishing between successfully and unsuccessfully
transformed bacteria cells.

A sample from a successfully transformed bacteria colony is taken and used to
progenerate a larger quantity of the plasmid of interest.
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Figure 7. Petri Dish with Transformed Bacteria Colonies.

Next, the transformed bacteria are transferred into a test tube with growth media
and antibiotic, and then swirled for 12 hours. The combination of growth media
containing amino acids and sugars, and a continuous swirl provides the
necessary building blocks, energy, and shear stimulation for proliferation.
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Figure 8. New Brunswick C-24 Incubator and Shaker. This machine contributes
to an ideal growth environment by maintaining the proper temperature and
shaking the samples.

The bacteria culture is then scaled-up one more time by transferring the test tube
contents into 1L Erlenmeyer flasks and then proliferated in a larger ideal growth
environment.
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Figure 9. Large Scale Inoculation. The Innova 4 provides a very similar
environment as the New Brunswick C-24, but it is designed to shake 1L flasks
instead of test tubes.

Step 4: Harvesting DNA
Once the transformed bacteria are proliferated to an adequate level, appropriate
steps must be taken for safe and effective separation of the desired plasmid from
the rest of the cell. First, the bacteria are separated from the growth media by 30
minutes of high speed centrifugation with a radial acceleration of 4,500 times that
of gravity.
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Figure 10. Sorvall RC3B Centrifuge. This centrifuge is used to spin down the
bacteria and, later in the process, the purified DNA.

Figure 11. Bacteria Pellet. Pellets of bacteria stuck to the side of the container
and growth media. The resulting pellet of bacteria is separated by carefully
pouring off the growth media.

Next, the pellet is suspended in a solution of lysis buffer and ribonucleases which
destroys the cell wall and degrades the newly exposed RNA, respectively. After
a few minutes of gentle agitation, the lysate and ribonucleases are deactivated
with a neutralization buffer. The buffer also precipitates the cell debris, proteins,
12

genomic DNA and lysate. This mixture is first pulled through a filtration cartridge
which removes the precipitated material. The residual aqueous solution of
dissolved RNA and DNA is then pulled through a binding cartridge.

Figure 12. Filtration and Purification Station. The solution is poured in the top
container of the apparatus and a vacuum is attached to the bottom canister to
facilitate flow through the filtration or binding cartridge. This setup is used for the
cell debris filtering cartridge and the RNA and DNA binding cartridge.

The binding cartridge is composed of a positively charged resin which binds the
negatively charged DNA and RNA molecules. Once the solution has passed
through the cartridge and the DNA and RNA has been bound, a salty wash buffer
is run through the cartridge twice, disrupting the electrical attachment of the
nucleotides. The first wash of salt solution disrupts the loosely bound RNA which
is captured in a beaker and discarded. The second wash removes the more
13

tightly bound DNA molecules from the resin and is captured in another beaker.
At this point, the plasmid DNA is relatively free from RNA and protein
contaminants; however, one more step is taken for further purification. The
plasmid DNA is then precipitated with isopropanol, washed with 80% ethanol and
centrifuged into a pellet. Finally, the DNA pellet is suspended in TE buffer which
maintains an ideal pH and protects against degradation.

Figure 13. DNA Pellet. Centrifugation of the suspended DNA packs the DNA
into a pellet enabling easy separation from the media.

Step 5: Analyzing and Verifying the DNA Identity, Purity and Concentration
Once the plasmid DNA has been purified, a small sample is taken to evaluate the
amount of DNA yielded by the process. This is accomplished using a
spectrophotometer. The spectrophotometer evaluates concentration of DNA
based on the amount of light absorbed by the sample. Light is emitted at 260nm,
which is the wavelength DNA absorbs, and the instrument calculates a
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concentration based on the amount of light that passes through (not absorbed)
the sample relative to a blank sample.

Figure 14. Nanodrop Spectrophotometer. 1-2 µL of purified plasmid is pipetted
onto the Nanodrop to evaluate the DNA concentration.

Once the DNA concentration has been determined, it must be evaluated for
purity and positively identified. To accomplish this, the purified DNA is digested
by a set of restriction enzymes and then electrophoresed to separate the different
pieces of DNA molecules based on size and shape.
A restriction enzyme, a particular type of endonuclease, cuts the backbone by
catalyzing the hydrolysis of the phosphodiester bonds at specific sequences of
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nucleotides. These specific sequences are known as recognition sites, most of
which are palindromic and six nucleotides long.

Figure 15. Restriction Enzyme Reaction. The breaking of the phosphodiester
bonds of the DNA backbone is a result of a nucleophilic attack by the enzyme
complex on the electrophilic phosphorous atom.

Knowing the sequence of a purified plasmid and the recognition sites for many
restriction enzymes allows the plasmid to be cut into predictable lengths. With
this knowledge, Life Technologies designed their restriction digests by pairing
plasmids with a specific group of restriction endonucleases. The expected
lengths of DNA can be compared to the actual DNA strands resulting from the
digest as a means of identifying the plasmid sequence.
Using this technique, a sample of the plasmid, digested by restriction enzymes, is
pipetted into multiple wells in an electrophoresis gel. During electrophoresis, an
electric field is set up across the gel box. Over time the negative DNA molecules
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move through the gel towards the positive side. The smaller molecules are able
to move more quickly through the gel creating a method of separation based on
size.

Figure 16. Electrophoresis Gel Box. The electric field is set up so that the
negatively charged DNA starts on the negative end of the box. Negatively
charged molecules then travel toward the positive side at rates proportional to
their size.

Once the electrophoresis is complete, the agar gel and DNA are stained with
ethidium bromide (EtBr). EtBr binds with the DNA and moves in between its
hydrophobic base pairs which stretches the DNA fragment and removes water
molecules from the ethidium cation. The result of this dehydrogenation is an
increase in fluorescence of the ethidium.
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Figure 17. DNA Electrophoresis Gel. The column on the left is called the ladder.
The columns to the right are DNA molecules. Each line of the ladder corresponds
to a different size molecule with the lines closest to the bottom being the smallest
molecules. The ladder provides a way of indirectly measuring the size of the
pieces of cut DNA.

The purity of the DNA can be determined by comparing the amount of Genomic
DNA, which is large and travels the shortest distance, to the Plasmid DNA. This
ratio of Genomic DNA over total DNA (Genomic plus Plasmid DNA) is presented
as a percent purity. The amount of plasmid DNA as a percent of total DNA can
then be multiplied by the concentration to determine the amount of Plasmid DNA.
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Shortcomings of DNA Purification and Analysis
The end product is sold at a specific concentration of plasmid DNA, so the
product must be well characterized during manufacturing to accurately market
the product. The lack of precision in the separation and purification of the
plasmid DNA from the genomic DNA and cell debris resulted in decreased yield
and a lack of purity. The final step of confirming the correct identity of the
plasmid and the level of purity were also in need of improvement. The identity
confirmation was inconclusive, and the purity check was subjective. In order to
improve the end product, both the harvesting and yield analysis steps of the
process were investigated for improvement.
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II.

Objectives and Approach

There were three fundamental objectives: 1) improve the conclusiveness of the
plasmid identification protocol, 2) reduce the ambiguity of the plasmid purity
evaluation protocol, and 3) improve the purity and yield of the plasmids with
regard to genomic DNA.

Improving the Identification Protocol
The pre-existing identification protocol was inherently inconclusive and had an
unacceptably high rate of returning a false negative. It utilized a set of restriction
enzymes to cut the strand of plasmid DNA at multiple locations. The restriction
digest product was then electrophoresed, and the lengths of the resulting strands
of DNA were compared to the expected lengths. If they all matched, the plasmid
was identified as correct.
There were a few problems with this technique: the restriction enzymes being
used were highly susceptible to damage during storage which results in
unpredictable behavior; some of the cut sites were highly susceptible to
methylation which blocks the enzyme from cutting the DNA; and the inherent
possibility that an incorrect plasmid could coincidentally yield the expected
lengths of DNA strands. To improve the identification step, an entirely new
protocol was developed.
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The new identification protocol sequences the manufactured plasmid and then
compares the sequence of nucleic acids unique to that plasmid, approximately
300 long, to what the sequence is supposed to be. The result is a direct
comparison, one nucleic acid at a time, of the manufactured plasmid against the
correct sequence, resulting in an unequivocally conclusive test. To implement
this new protocol, a unique region of each plasmid had to be determined, a
database of each plasmid and its identification sequence developed, and a
method for sequencing and comparison installed.

Improving the Purity Analysis Protocol
The pre-existing protocol, which analyzed the percent genomic DNA in the
purified sample, was highly subjective. The protocol called for the purified DNA
to be electrophoresed in an agar gel, and then stained with EtBr. Because the
strand of plasmid DNA is much smaller than genomic DNA, the two molecules
travel at different rates during electrophoresis and are thus separated. A picture
of the stained gel was taken under ultraviolet light, and an operator then made a
subjective assessment of the purity by comparing the extent to which EtBr was
bound to each type of DNA molecule. Because of the subjective nature of this
protocol, the purity evaluation was neither precise nor reproducible.
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Figure 18. Previous Electrophoresis Gel. An image of an electrophoresis gel
used in the pre-existing purity protocol. DNA banding is imprecise.

One of the objectives of this project was to develop a new purity protocol utilizing
software that essentially quantifies the luminescence of the stained DNA, which
is directly proportional to the amount of DNA.

Improving the yield of the Purification Process
Until the reproducibility of the purity evaluation technique was improved, the
purity and yield of the entire purification process could not be evaluated for
improvement. Once the process could be accurately evaluated for purity, the
correct yield could also be determined. With that metric now available, a
strategic plan of investigation was developed to specialize the purification
process for each plasmid.
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III.

Methods and Materials

Improving the Identification Protocol
Once the plasmid has been purified, it is important to verify its identity. The preexisting method was inconclusive and its components were prone to
malfunctioning. The new method provides a decisive evaluation of each
nucleotide by sequencing the DNA in a region of the plasmid that is uniquely its
own.
To achieve this, a sample of the purified plasmid of interest is sent to a local
genetic sequencing company where the identifying DNA is sequenced. But first,
a region to be sequenced must be identified. Determining the region appropriate
for confirming the plasmid’s identify was the first step to improving the
identification process.
Life Technologies holds a database with the nucleotide sequence for each
plasmid of interest.
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Figure. 19. Raw Plasmid Sequence. An example of a plasmid sequence before
it is entered into Vector NTI. Analysis in this format without a bioinformatics
program is tedius and inefficient.

These sequences were transferred into a bioinformatics program called Vector
NTI. This software enables the search of specific sequences within the molecule
so that genes, primer recognition sequences and enzyme recognition sites can
be efficiently identified and labeled.
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Plasmid A

Plasmid A

Figure 20. Vector NTI Pictorial of Plasmid. The markers identify restriction
enzyme recognition sites and regions that code for particular proteins.

The majority of the plasmid’s genetic code is not unique to itself. Most plasmids
code for a multitude of proteins necessary to carry out basic cell life that are
common amongst a group of similar cells. The unique region of the plasmid that
is used for its identification is called the Multiple Cloning Site (MCS). The MCS is
a synthetic region of the plasmid with a particularly high concentration of
25

restriction enzyme sites. It enables a wide range of insert locations for a scientist
designing new genes into a plasmid and is the location of the genetically
engineered genes of interest. Once the MCS is located, primer sequences on
either side of it are identified for sequencing.

Figure 21. Life Technologies’ Product Manual Sequence Description. This was
used in concert with the Vector NTI map for primer design.

With the identifying region located and the surrounding primers determined, the
plasmid can be sent out for sequencing.
The DNA is sequenced by separating the two phosphate-deoxyribose
backbones, creating two single-stranded DNA molecuels. The primers
surrounding the region of interest then coordinate with their corresponding
sequence of nucleic acids and catalze DNA Polymerase’s elongation of the
26

complimentary strand. This is done in the presence of deoxyribonucleotide
monomers (dNTP), the single units of a DNA strand, and a dideoxyribonucleotide
triphosphate analog (ddNTP). The ddNTP’s are dNTP’s with the 3’-OH group
replaced with a 3’-H. This substitution renders the ddNTP unable to form the
phosphodiester bond between dNTPs, thus terminating elongation of the strand.

Figure 22. Molecular Structure Illustration. An Illustration of the structural
difference between deoxyadenosine triphosphate (dATP) and dideoxyadenosine
triphosphate (ddATP).

Four reactions are carried out in parallel, each with a different ddNTP:
dideoxyadenosine triphosphate (ddATP), dideoxythymidine triphosphate
(ddTTP), dideoxyguanosine triphosphate (ddGTP), and dideoxycytidine
27

triphosphate (ddCTP). Each of the four reactions incorporates a different
flourophore that modifies the corresponding ddNTP. The four reactions are then
run through an electrophoresis gel to determine molecular length and constituent
nucleotides are identified according to light emission properties of the different
fluorophores. In this way a large population of randomly sized DNA molecules
with a known number of base-pairs can be evaluated. This process is highly
automated allowing thousands of nucleotides to be identified in minutes. The
evaluation program then produces a read-out similar to the one below.

Figure23. Typical Sequencing Read-out. Each colored peak corresponds to a
specific wavelength and nucleotide. The height of the peak is a representation of
the strength of the nucleotide identity as determined by number of matches.

With the DNA sequenced, the identity of the purified plasmid can be compared,
nucleotide by nucleotide, to the correct sequence for conclusive positive
identification. Figures 24 and 25 illustrate how Vector NTI is used to compare
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the actual plasmid DNA, as determined by the outsourced sequencing company,
with the Identification Sequences in Life Technologies’ database.
The ContigExpress application of Vector NTI compares the sequence identified
by the outsourced sequencing company with the known Identification Sequence
in Life Technologies’ database.

Figure 24. ID Sequence Lay-out. Pictorial representation of how sequenced
DNA is spatially coordinated with the Identification Sequence in Life
Technologies’ database.

Each MCS has three versions (A, B and C), one for each place in the reading
frame. This allows for flexibility when designing the MCS into a particular
plasmid. Accordingly, there are three Identification Sequences per MCS per
plasmid. In Figure 24, the three bands in the middle correspond to the A, B and
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C versions of the plasmid Identification Sequences. Above are the 3 forward
priming sequences (there is a duplicate of each for insurance resulting in a total
of 6). Below the Identification Sequences are the reverse priming sequences
with the same redundancy as the forward priming sequences. As illustrated,
neither the forward nor the reverse priming sequence individually spans the
entire Identification Sequence; but together, with some overlap, the entire
Identification Sequence can be compared.

Figure25. ContigExpress. An image of how ContigExpress compares the
sequences in Figure 24 Nucleotide by nucleotide. It is here that the
determination of correct identification is made. The highlighted discrepancies in
the middle are due to the single and double nucleotide shifts of the A, B and C
reading frames.
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Improving the DNA Purity Analysis Protocol
The first step was to change the type of electrophoresis gel used. The preexisting protocol used Life Technologies’ E-Gel®, a prepackaged electrophoresis
gel with a built-in ladder and its own electric field source. These E-Gels,
however, run too hot for our application, causing denaturation, which results in
“smiling” of the DNA bands. Smiling DNA decreases the readability and
precision of the banding. The E-Gels were replaced with hand-poured gels
which run at an appropriate temperature and are more customizable. The result
is a more precise and reliable DNA banding pattern.

Figure 26. E-Gel with “Smiley Faces”. These pre-packaged electrophoresis gels
used in the pre-existing protocol ran too hot. This caused denaturation of the
DNA resulting in “smiley face” bands. The bands of the ladder are also distorted.
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Figure 27. Hand-Poured Gel. These gels run at a more appropriate temperature
and provide a higher degree of customization. The result is a more precise DNA
size gradation.

With the hand-poured electrophoresis gels, the banding is more consistent, but
the ambiguity of the purity analysis still needed to be removed. To eliminate the
subjective nature of the protocol, evaluation was changed from a visual
assessment by a technician to pixel evaluation by computer software.
A 2UV Transilluminator was used to capture an ultraviolet image of the gels.
Then VisionWorksLS software was used to quantify the amount of each type of
DNA based on the density of black and white pixels.
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Figure 28. 2UV Transilluminator.

Figure 29. Density Box. An example of the defined region used to evaluate the
quantity of DNA in the band.

After electrophoresis on the digested DNA is complete, the gels are stained with
EtBr. EtBr binds to the DNA and fluoresces when exposed to ultraviolet light
from the 2UV Transilluminator. The fluorescence of the gel is then captured by
the 2UV Transilluminator and communicated to the VisionWorksLS imaging
33

software. The imaging program enables the user to view the DNA bands and
employ objective numerical evaluation techniques.

Figure 30. VisionWorksLS Imaging Software Interface.

Once captured by the viewing software, the electrophoresed banding patterns
become readily apparent. Each purified plasmid is electrophoresed into two
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columns, one that has been digested by a restriction enzyme and one that has
not been digested.

Nicked DNA

Nicked DNA

Figure 31. Electrophoresis Banding Pattern. An illustration of typical
electrophoresis banding patterns for digested and undigested plasmids.
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The first column, starting from the left, of each pair contains the purified sample
that has not been digested. When the undigested purified plasmid is
electrophoresed, 3 prominent bands show up. The largest molecular band is the
genomic contamination, which is essentially what the purity analysis is evaluating
for. The next largest band is nicked plasmid, or open circular DNA with one
strand cut. And the third band, the smallest molecule, is the supercoils of DNA.
The electron micrograph image below is a helpful illustration of these three
common conformations.

Figure 32. Electron Micrograph Image of Bacterial DNA Plasmid.

The second column contains the same purified plasmid as the first, but has been
cut once by a restriction enzyme. The predominate band in this column is the cut
supercoil of DNA. The cut plasmid runs more slowly during electrophoresis
because there is more friction associated with a long strand of DNA than with the
balled up circular version of the same molecule. More surface area results in
more molecular interaction at the surface. Above the cut plasmid is what is
36

called a “smear”. The smear is caused by the genomic contamination and is the
result of the restriction enzyme cutting it into many different size molecules.
For our purposes, we used the program to evaluate the amount of DNA present
in each band relative to other bands. Because the amount of DNA is directly
proportional to the amount of fluorescence, the software can quantify the amount
of DNA as a function of the pixel density.

Figure 33. Defined Density Boxes.
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37050.3367

Total
Background
70099.5005

Mean
Density
14.4728

Mean
Background
27.3826

Total Raw
Density
106816

Mean Raw
Density
41.725

2

240366.2647

70099.5005

93.8931

27.3826

310463

121.2746

3

228948.4995

70099.5005

89.433

27.3826

299048

116.8156

4

9536.3606

70099.5005

3.7251

27.3826

79621

31.102

5

53103.03

70099.5005

20.7434

27.3826

123201

48.1254

6

163776.4995

70099.5005

63.9752

27.3826

233876

91.3578

7

135507.2388

70099.5005

52.9325

27.3826

205590

80.3086

Region

Total Density

1

Table 1. Raw Density Data from VisionWorksLS Software. The “Total Raw
Density” refers to the number of white pixels in a particular boxed region. This is
the value used to calculate DNA quantities

To calculate the percent genomic contamination in the purified plasmid sample,
the density of the genomic DNA was divided by the total DNA (supercoil plus
genomic). The ratio of supercoil to linearized plasmid is an indication of the
condition of the supercoil.
In order to validate the reproducibility of the software-analyzed protocol, three
sets of purified plasmids were electrophoresed at three different volumes. Each
set was evaluated for both linearity of quantity vs. volume, and the variance of
percent genomic contamination at 95% confidence.
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Improving the Yield of the Purification Process
With the new purity quantification technique, it became possible to accurately
evaluate the purity and yield of the purification process. Retains of each
manufactured batch of purified plasmids for the last several years had been
preserved in a freezer at -4°C. They were easily categorized by purification kit
type: 1) MegaPrep, 2) GigaPrep and 3) Maxicard. For all three categories, the
functional chemistry is the same. MegaPrep and GigaPrep are essentially the
same process except for a difference in the size of the filtration cartridges used to
separate the DNA from proteins and larger cell debris.

Cartridge

Figure 34. Filtration Cartridge. Filtration cartridge used in MegaPrep and
GigaPrep purification processes.
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Table 2. Megaprep/Gigaprep Specifications. Specification table indicating the
difference between Megaprep and Gigaprep purification capabilities.

Maxicard is an all-inclusive automated machine that carries out the entire
purification process – from bacteria culture to purified DNA – but on a much
smaller scale than either MegaPrep or GigaPrep.
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Figure 35. Maxicard Purification Machine.
Retains purified by each category of filtration were digested with an appropriate
restriction enzyme, as described above, and evaluated against a multitude of
metrics in an effort to discern any indication as to which was most appropriate for
each type of plasmid.
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IV.

Results and Discussion

Identification Assay
Nearly 25 plasmid characterization files were created in Vector NTI and verified
with their sequenced genetic code. Below are the identification validation results
of a typical plasmid family.
The out-sourced sequencing company returned the sequenced DNA information
in the format below.

Figure 36. Sequence Data. The sequenced plasmid file returned by the outsourced company. The “N’s” are a result of imprecision localized around the
primers.
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The sequence file was then imported into Vector NTI and compared to the
expected DNA sequence file (SeqID) in Life Technologies’ database.

Figure 37. SeqID File. Above is the SeqID file against which the sequenced DNA
is compared to.

The sequenced DNA file and SeqID are compared in a VectorNTI application
called ContigExpress, shown below.
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Figure 38. ContigExpress Identification Evaluation.
The sequenced DNA matches each corresponding SeqID file. The highlighted
region of the plasmid is due to the frame shifts of the A/B/C versions. From these
matches the identity of each plasmid is confirmed.
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Purity Analysis Assay Results
In order to determine the reproducibility of the VisionWorksLS density
measurement software, three different volumes (250 µL, 500 µL and 1000 µL)
were electrophoresed for three different purified plasmids.

Figure 39. Purity Evaluation Verification Gel. Three different plasmids were
evaluated, each at three different loaded quantities, in order to verify the
reproducibility and linearity fit of the evaluation technique.
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DNA

ng loaded

Total Density

Type

Plasmid 1

1000

252344

Supercoil

Plasmid 1

500

169193

Supercoil

Plasmid 1

250

101969

Supercoil

Plasmid 2

1000

218039

Supercoil

Plasmid 2

500

136203

Supercoil

Plasmid 2

250

67540

Supercoil

Plasmid 3

1000

222855

Supercoil

Plasmid 3

500

104198

Supercoil

Plasmid 3

250

82435

Supercoil

Plasmid 2

1000

47703

Plasmid 2

500

22647

Plasmid 1

250

13165

Plasmid 2

1000

82142

Plasmid 2

500

38166

Plasmid 2

250

Plasmid 3

%SC

%Total

Genomic DNA

19%

16%

Genomic DNA

13%

12%

Genomic DNA

13%

11%

Genomic DNA

38%

27%

Genomic DNA

28%

22%

16971

Genomic DNA

25%

20%

1000

62736

Genomic DNA

28%

22%

Plasmid 3

500

23914

Genomic DNA

23%

19%

Plasmid 3

250

17839

Genomic DNA

22%

18%

Table 3. Purity Calculations. Software density calculations for gel shown in
Figure 38.

Analysis on the resulting data showed satisfactory results with percent genomic
contamination confidence intervals of 2.2%, 3.5% and 2.0% at 95% confidence,
well within the desired 95% confidence range of 5%. An additional regression
analysis, shown below, on the linear fit of the data points found excellent R2
values for the slope of DNA quantity vs. volume: 0.9806, 0.9834, 0.9647, 0.9999,
0.9958 and 0.9572. These values indicate a high degree linear relationship
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between the points among each DNA type of each plasmid and further suggest
that this analysis technique is reproducible and robust.

Pixel Density vs Volume
300000
R² = 0.9806

DNA (pixel density)

250000

Plasmid1Genomic

R² = 0.9834
R² = 0.9647

200000

Plasmid2Genomic
Plasmid3Genomic

150000

Plasmid1Plasmid

R² = 0.9999
R² = 0.9958

100000

Plasmid2Plasmid

R² = 0.9572

Plasmid3Plasmid

50000
0
0

200

400

600
Volume (µL)

800

1000

1200

Figure 40. Pixel Density vs Volume. This graph shows the linearity between
pixel density and quantity of DNA.

With the new Purity Analysis Assay verified for reproducibility, all the available
plasmids from the previous year were analyzed for percent genomic
contamination. Using the technique described in Methods and Materials, a table
was developed to: 1) evaluate the purity of the previous year’s product and 2)
build a spreadsheet of data from which to evaluate individual parameter
contribution to yield and percent genomic contamination.
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N
a
m
e
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R

HF
Enzyme

Media
type

Yield (ug)

BamHI
BamHI
BamHI
BamHI
BamHI
BamHI
BamHI
BamHI
BamHI
BamHI
BamHI
BamHI
BamHI
BamHI
EcoRI
EcoRI
EcoRI
EcoRI

LB
TB
TB
TB
TB
TB
TB
TB
TB
TB
TB
TB
CW
TB
LB
LB
LB
LB

750
7240
6420
7480
9000
6127
8400
13550
13550
13550
13550
13550
14600
9150
1615
995
435
1836

%g
DNA

SC/Linear

9%
3%
10%
11%
17%
11%
19%
5%
11%
10%
9%
7%
11%
14%
26%
8%
14%
21%

0.98
1.02
1.91
1.13
1.47
0.34
1.43
0.89
0.83
0.76
0.75
0.85
0.81
1.34
0.96
0.77
1.51
1.05

Size

5500
3890
3890
3890
3890
3890
3890
3890
3890
3890
3890
3890
3890
3890
4102
4102
4102
4102

Scale

MC
GIGA
GIGA
GIGA
GIGA
GIGA
GIGA
GIGA
GIGA
GIGA
GIGA
GIGA
GIGA
GIGA
MEGA
MEGA
MEGA
MEGA

ug
DNA/g
cells
2532
724
321
748
450
306
420
678
678
678
678
678
1502
458
508
332
146
291

Table 4. Plasmid Characterization. Abbreviated version of the table used to
discern suggested parameter effects on yield and purity. From this table,
patterns were suggested, hypotheses were developed, and experiments were
designed to test those hypotheses.

The Plasmid Characterization Table suggested a few trends. The strongest
suggestion was that the size of the plasmid had an effect on purity.
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Figure 41. Genomic Contamination vs Plasmid Size (bp). This graph suggests
the larger plasmids have lower contamination.

One explanation for this trend is that larger plasmids have more negative charge
to attach to the positively charged purification column, resulting in a greater
degree of purification. This trend may be useful in predicting purity of different
size plasmids; however, the size of the plasmid is determined by the proteins
coded in the DNA and cannot be altered to improve purity.
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The data in Figure 41 also indicated a possible correlation between the amount
of bacteria culture which was purified and the size of the purification columns
used during purification.

Figure 42. Genomic Contamination vs Purification Scale. This table suggests the
GigaPrep purification scale achieves the least contamination.

The MaxiCard (MC) purified plasmids had the lowest contamination; however,
they always use the same volume and concentration of bacteria, which is
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significantly lower than the GigaPrep and MegaPrep purified plasmids.
Unfortunately, MaxiCard purification cannot be scaled up to support the high
volume purification requirement of most plasmids. Between the two scales of
purification which can support high volume production, the data indicate Giga is
better than Mega. As with most types of filters, GigaPrep and MegaPrep
purification columns can be over-loaded. GigaPrep is the larger of the two and
can most likely support higher volumes of media before reaching its over-load
threshold. This reasoning led to the hypothesis that increasing amounts of
bacteria to be purified results in an increasing level of contamination. To test this
hypothesis, plasmids were purified at varying quantities using the same scale of
purification, and evaluated for trends between quantity of bacteria purified and
genomic contamination level.

Yield Assay
Based on the suggested correlations in Table 4, varying quantities of bacteria
were purified using MegaPrep kits to provide insight into the correlation between
bacteria quantity and purity.
Two different plasmids were purified at 4 different quantities, shown in Table 5, in
an effort to evaluate the effect of the amount of bacteria and DNA purified on
purity.
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PBAD HIS B

PBAD GIII B

Culture (mL)

500

750

1000

1250

750

850

900

1000

Bacteria (g)

2.69

4.74

5.57

9.23

3.94

5.35

5.79

5.78

DNA Yield (ug)

408

1590

1000

680

3170

3480

7940

7940

Yield/Bacteria

152

335

180

74

805

650

1371

1374

% gDNA

11

18

13

15

11

21

17

17

Table 5. GigaPrep Purity and Yield Assay Results. “Culture” is the volume of
bacteria culture. “Bacteria” is the mass of bacteria in the culture. “DNA Yield” is
the mass of DNA resulting from the purification process. “% gDNA” is the percent
of total DNA which is genomic.

To help provide perspective, the results from Table 5 were graphed as purity vs
the raw amount of DNA yielded, and purity vs the ratio of DNA yielded over mass
of bacteria purified. The first graph is the most direct measurement of how the
amount of DNA purified affected the quality of purification. The second graph
illustrates how purity and the density of DNA in the bacteria are related.
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MegaPrep
Purity vs Bacteria Quantity
25
20
15
% gDNA
10
5
0
0

2

4
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8
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Bacteria (g)

Figure 43. MegaPrep Purity vs Bacteria Quantity.

There appears to be a trend of increasing percent genomic contamination as
amount of DNA purified increases. This corroborates the theory that the charged
column used to separate the DNA from the protein and RNA loses its
effectiveness as it approaches a saturation point.
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MegaPrep
Purity vs Efficiency
25
20
15
% gDNA
10
5
0
0

500

1000

1500

Yield/Bacteria

Figure 44. MegaPrep Purity vs Efficiency.

The ratio of DNA yielded over bacteria purified was initially looked at as an
indication of the efficiency of the purification process. Except for the outlier at
approximately 800, the % genomic contamination seems to be increasing with
efficiency. However, the amount and type of DNA produced by the bacteria can
play as large a role here as the effectiveness of the purification process. For
example, different plasmids replicate at different rates relative to the host cell’s
genomic DNA. This means that different plasmids result in varying amounts of
plasmid DNA relative to genomic DNA before the purification process begins.
Also, given an equal plasmid replication rate relative to the genomic replication
rate, an 8K bp plasmid will have half the genomic contamination of a 4K bp
plasmid. Even though the number of plasmids is the same, because the
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measurement is based on the quantity of constituent amino acids, not the
number of plasmids themselves, the level of genomic contamination will differ.
Four plasmids were purified using the MaxiCard purification machine. The
results are shown in Table 6. Because this machine requires a specific volume
and concentration, these values are the same for all four plasmids. This
consistency provided an opportunity to investigate the effect of plasmid size while
controlling volume and concentration.

PDEST40#1 PDEST40#2 PEF5 PBADHIS
Size (bp)

7100

7100

7500

4100

Culture (mL)

125

125

125

125

Bacteria (g)

0.275

0.275

0.275

0.275

DNA Yield (ug)

609

766

890

23

Yield/Bacteria

2215

2785

3236

84

% gDNA

9

24

6

13

Table 6. MaxiCard Purity and Yield Assay Results.

The graphed results show a trend of decreasing genomic contamination as
efficiency increase, except for the outlier at 24%. This data suggests a possible
trend, but more data points are needed to a statistically significant trend.
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MaxiCard
Purity vs Efficiency
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Figure 45. MaxiCard Purity vs Efficiency.

MaxiCard
Purity vs Plasmid Size
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Figure 46. MaxiCard Purity vs Plasmid Size.

56

6000

7000

8000

As with the MegaPrep purified plasmids, genomic contamination, except for one
data point, seems to decrease as plasmid size increases. This is possibly due to
more attractive forces between the purification column and the plasmid due to
the increased number of base pairs; or the result of a larger plasmid containing
more DNA. The larger plasmid, given the same number of plasmid molecules
and same amount of genomic DNA, will always have a lower level of genomic
contamination.
Overall, the data suggests purity is most significantly affected by both purification
scale and plasmid size. However, none of the experiments have enough data
points to validate these theories with statistical significance. Further experiments
are needed to confirm this hypothesis.
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V.

Conclusion and Future Works

Identification Assay
The new protocol for confirming the correct identity of the purified plasmid is an
improvement in many ways. The new method is simpler, more robust and less
expensive. There are no inconclusive results due to false negatives and
methylation, and the unstable restriction enzymes have been obviated.
Compared to the old paradigm, there is essentially zero ambiguity of a correct
match.
While currently very effective, an internal control sequence within the plasmid
may be worth investigating. In the event that there is a bad sequencing reaction
or bad DNA, a control sequence would create a secondary control. Also, it may
be worth looking into an alternative unique region for comparison.

Purity Assay
The new purity evaluation process is a vast improvement over the extreme
ambiguity and variability of the previous method. However, the amount of time
that the DNA is soaked in the stain, and the time it is de-stained is not regulated.
Consistent staining would improve the probability that the DNA in each gel
interacts equally with the EtBr. Different types of stains could possibly optimize
the consistency and speed of the process as well.
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Yield Assay
The yield assay suggested some interesting trends with regard to the most
significant factors affecting genomic contamination. While plasmid size and
purification scale seem to play a large role and should be further investigated, it
would be useful to research the replication rate of different plasmids relative to
the host cell chromosome. This relative replication rate would provide insight into
the ratio of genomic DNA to plasmid DNA, inherent in the biology, which certainly
affects the yield of the purification process.
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